Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

AorTech International Director/PDMR Shareholding

6 Apr 2009 07:00

RNS Number : 1524Q
Aortech International PLC
06 April 2009
 



AorTech International plc (the "Company")

Director / PDMR Shareholding 

The Company has been informed that on 3 April 2009 Jon Pither, Frank Maguire and Stuart Rollason, all Directors of the Company, purchased a total of 97,900 ordinary shares of 250p each in the Company ("Ordinary Shares"), at a price of 130 pence per Ordinary Share, of which 60,000 were purchased from Eddie McDaid and Gordon Wright, also both Directors of the Company. Their resultant interests of the Directors are as follows:

 

Director

Ordinary Shares acquired 

Ordinary Shares sold

Resultant holding

% of the current issued share capital

Jon Pither 

15,050

-

15,050

0.31

Frank Maguire

79,850

-

81,050

1.68

Stuart Rollason

3,000

-

11,825

0.24

Eddie McDaid

-

30,000

333,383

6.90

Gordon Wright*

-

30,000

305,107

6.31

*Gordon Wright's shares are held through Caricature Investments Ltd.

6 April 2009

Enquiries:

AorTech International plc 

Frank Maguire, Chief Executive 

Tel: + 1 801 201 4336 

Evolution Securities 

Bobbie Hilliam / Chris Clarke 

Tel: +44 20 7071 4300 

AorTech International plc 

Sarah Price, Investor Relations 

Tel: + 1 801 550 4349 

e-mail sprice@aortech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQXLFBKZBLBBB
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.